Toggle navigation
Home
Search
Services
Blog
Contact
About
Ultrasonic Speckle Reduction
Gehlback, Steve M.
Kesa Corporation, Santa Clara, CA, United States
Search grants from Steve Gehlback
Search grants from Kesa Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Proteome Bead-Display for Discovery of Tumor Antigens
Emotional competence as a protective factor against risk and maladjustment for ch
Genetic regulation of Drosophila corpora cardiaca development and function
Syracuse Onondaga Drug and Alcohol Abuse Commission's DFCSP
Characterization of Macromolecules of Neoplastic Cells
Recently added grants:
The Role of Deoxysphingolipids in Peripheral Neuropathy
Hydroxynorketamine for the Treatment of PTSD and Anhedonia
DCLK1 is a Novel Molecular Target in Hepatocellular Carcinoma
Psychological stress reduces endocannabinoid tone: mechanisms and possible treatments
CD47 as a therapeutic target for obesity
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM057808-000
Application #
3613422
Study Section
Project Start
1985-09-30
Project End
Budget Start
1985-09-30
Budget End
1986-03-31
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Kesa Corporation
Department
Type
DUNS #
City
Santa Clara
State
CA
Country
United States
Zip Code
95054
Comments
Be the first to comment on Steve Gehlback's grant